Crestwood Advisors »

Inmed Pharmaceuticals shares owned by Crestwood Advisors

Quarter-by-quarter ownership of Inmed Pharmaceuticals (INM) shares owned by Crestwood Advisors from 13F filings

Historical chart of Crestwood Advisors investment in Inmed Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Inmed Pharmaceuticals held by Crestwood Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inmed Pharmaceuticals by Crestwood Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $23k 15k 1.55

More positions owned by Crestwood Advisors

Apple Stock (AAPL)
Ishares Core S&p 500 Etf Etf (IVV)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Nvidia Corporation Stock (NVDA)
Microsoft Corp Stock (MSFT)
Amazon Stock (AMZN)
Applied Matls Stock (AMAT)
Applied Finance Valuation Large Cap Etf Etf (VSLU)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Ishares Core U.s. Aggregate Bond Etf Etf (AGG)
Broadcom Stock (AVGO)
Lam Research Corp Stock (LRCX)
Kla Corp Stock (KLAC)
Visa Inc Com Cl A Stock (V)
State Street Spdr Portfolio S&p 600 Small Cap Etf Etf (SPSM)

View all positions for Crestwood Advisors

Top funds holding Inmed Pharmaceuticals

ADAR1 Capital Management
Vivo Capital
Squadron Capital Management
Ikarian Capital
Ursa Fund Management
Suvretta Capital Management
Boothbay Fund Management
Sabby Management
Jane Street
VR Adviser
Citadel Advisors
Seven Grand Managers
Scientech Research
Crestwood Advisors
Two Sigma Securities

View all funds holding Inmed Pharmaceuticals